nicotine partial agonists (Pfizer)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namenicotine partial agonists (Pfizer)
Drug Alias NameAlzheimers disease therapeutics (Pfizer)cognitive disorder therapeutics (Pfizer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinic receptors modulatorsNicotinic receptors partial agonists
TargetsNicotinic receptors
Therapy Area/IndicationsCognition DisordersAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsCognition DisordersAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A